These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37679646)

  • 1. Thrombopoietin level predicts the response to avatrombopag treatment for persistent thrombocytopenia after haploidentical haematopoietic stem cell transplantation.
    Fu H; Lv M; Liu H; Sun Y; Zhang Y; Mo X; Han T; Wang F; Yan C; Wang Y; Kong J; Han W; Chen H; Chen Y; Chen Y; Xu L; Liu K; Huang X; Zhang X
    Bone Marrow Transplant; 2023 Dec; 58(12):1368-1376. PubMed ID: 37679646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of avatrombopag for thrombocytopenia following allogeneic hematopoietic stem cell transplantation: A real-world data evaluation on 14 cases.
    Liu E; Fang P; Xin H; Li S; Liu Y; Xu Y; Chen Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):376-385. PubMed ID: 37164921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of the Spanish Group of Hematopoietic Stem Cell Transplant.
    Bento L; Bastida JM; García-Cadenas I; García-Torres E; Rivera D; Bosch-Vilaseca A; De Miguel C; Martínez-Muñoz ME; Fernández-Avilés F; Roldán E; Chinea A; Yáñez L; Zudaire T; Vaz CP; Espigado I; López J; Valcárcel D; Duarte R; Cabrera R; Herrera C; González-Porras JR; Gutiérrez A; Solano C; Sampol A;
    Biol Blood Marrow Transplant; 2019 Sep; 25(9):1825-1831. PubMed ID: 31152794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avatrombopag increases platelet count but not platelet activation in patients with thrombocytopenia resulting from liver disease.
    Michelson AD; Smolensky Koganov E; Forde EE; Carmichael SL; Frelinger AL
    J Thromb Haemost; 2018 Dec; 16(12):2515-2519. PubMed ID: 30264918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis.
    Armstrong N; Büyükkaramikli N; Penton H; Riemsma R; Wetzelaer P; Huertas Carrera V; Swift S; Drachen T; Raatz H; Ryder S; Shah D; Buksnys T; Worthy G; Duffy S; Al M; Kleijnen J
    Health Technol Assess; 2020 Oct; 24(51):1-220. PubMed ID: 33108266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the Efficacy and Safety of Avatrombopag Combined With MSCs for the Treatment of Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation.
    Zhu L; Liu J; Kong P; Gao S; Wang L; Liu H; Zhang C; Gao L; Feng Y; Chen T; Gao L; Zhang X
    Front Immunol; 2022; 13():910893. PubMed ID: 35693772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists.
    Gilreath J; Lo M; Bubalo J
    Drugs; 2021 Jul; 81(11):1285-1305. PubMed ID: 34160821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avatrombopag for the treatment of thrombocytopenia in children's patients following allogeneic hematopoietic stem-cell transplantation: A pilot study.
    Ruan Y; Cao W; Luo T; Liu X; Liu Q; Xiao Y; Wu C; Xie D; Ren Y; Wu X; Feng X
    Front Pediatr; 2023; 11():1099372. PubMed ID: 36873638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study.
    Al-Samkari H; Jiang D; Gernsheimer T; Liebman H; Lee S; Wojdyla M; Vredenburg M; Cuker A
    Br J Haematol; 2022 May; 197(3):359-366. PubMed ID: 35179784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Thrombopoietin Receptor Agonists in Prolonged Thrombocytopenia after Hematopoietic Stem Cell Transplantation.
    Mahat U; Rotz SJ; Hanna R
    Biol Blood Marrow Transplant; 2020 Mar; 26(3):e65-e73. PubMed ID: 31830528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avatrombopag for the treatment of thrombocytopenia post hematopoietic stem-cell transplantation.
    Zhou M; Qi J; Gu C; Wang H; Zhang Z; Wu D; Han Y
    Ther Adv Hematol; 2022; 13():20406207221127532. PubMed ID: 36185780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of switching to avatrombopag following treatment failure with eltrombopag in paediatric immune thrombocytopenia: A real-world study in China.
    Cheng X; Wang Z; Dong S; Ma J; Meng J; Wang X; Wu R
    Br J Haematol; 2023 Aug; 202(3):636-644. PubMed ID: 37188335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of avatrombopag in the management of severe and refractory chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors.
    Gao Y; Liu Q; Shen Y; Li Y; Shao K; Ye B; Shen Y; Zhou Y; Wu D
    Platelets; 2022 Oct; 33(7):1024-1030. PubMed ID: 35040375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional efficacy analysis of avatrombopag phase III data for the treatment of adults with immune thrombocytopenia.
    Jain S; Gernsheimer T; Kolodny S; Bernheisel C; Vredenburg M; Panch SR
    Platelets; 2023 Dec; 34(1):2195016. PubMed ID: 37013676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An updated evaluation of avatrombopag for the treatment of chronic immune thrombocytopenia.
    Song AB; Al-Samkari H
    Expert Rev Clin Immunol; 2022 Aug; 18(8):783-791. PubMed ID: 35793401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avatrombopag: A Review in Thrombocytopenia.
    Markham A
    Drugs; 2021 Nov; 81(16):1905-1913. PubMed ID: 34709601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structure, function, and clinical use of the thrombopoietin receptor agonist avatrombopag.
    Kuter DJ
    Blood Rev; 2022 May; 53():100909. PubMed ID: 34815110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of thrombopoietin receptor agonists in the treatment of thrombocytopenia after hematopoietic stem cell transplantation: a meta-analysis and systematic review.
    Yao Y; Tang Y; Qi J; Li X; Zhang R; Xu X; Pan T; Han Y
    Expert Rev Hematol; 2021 Nov; 14(11):1041-1048. PubMed ID: 34844489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avatrombopag for the treatment of thrombocytopenia in patients with chronic liver disease.
    Xu H; Cai R
    Expert Rev Clin Pharmacol; 2019 Sep; 12(9):859-865. PubMed ID: 31352834
    [No Abstract]   [Full Text] [Related]  

  • 20. An evaluation of avatrombopag for the treatment of thrombocytopenia.
    Virk ZM; Kuter DJ; Al-Samkari H
    Expert Opin Pharmacother; 2021 Feb; 22(3):273-280. PubMed ID: 33095074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.